The changing clinical trials scene: the role of the IRB.
D000163:Acquired Immunodeficiency Syndrome; D035061:Control Groups; D016638:Critical Illness; D026724:Ethical Review; D004989:Ethics; D017041:Ethics Committees; D028741:Ethics Committees, Clinical; D028744:Ethics Committees, Research; D035082:Federal Government; D005249:Fees and Charges; D006076:Government; D033161:Government Regulation; D006331:Heart Diseases; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D009042:Motivation; D005791:Patient Care; D018579:Patient Selection; D010361:Patients; D004364:Pharmaceutical Preparations; D010919:Placebos; D011897:Random Allocation; D012106:Research; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D012959:Socioeconomic Factors; D019452:Terminally Ill; D036302:Therapeutic Human Experimentation; D020458:Third-Party Consent; D014481:United States; D014486:United States Food and Drug Administration; D035862:Vulnerable Populations
Biomedical and Behavioral Research